Can Pharma Find Reputation Redemption? скачать в хорошем качестве

Can Pharma Find Reputation Redemption?

At their core, pharmaceuticals improve our quality of life and help save lives. During the past few decades, however, the innate tensions between profit expectations and noble healthcare goals have made headlines and tarnished the reputation of the entire pharmaceutical industry. With a world in the midst of COVID-19, governments, businesses, and the public now look to the industry as a healthcare innovator with the hope it can help end the pandemic. This webinar examined the immediate positive sentiment the industry is receiving, as well as the opportunities and challenges it faces to continue this reputation redemption during the pandemic and afterwards. Panelists: John Breen, Executive Director of Health Strategy, kyu Rob Jekielek, Managing Director, The Harris Poll Michael Sneed, Executive Vice President, Global Corporate Affairs & Chief Communication Officer, Johnson & Johnson Sally Susman, Executive Vice President & Chief Corporate Affairs Officer, Pfizer Moderated by: Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program, Columbia Business School Hosted by: Center on Global Brand Leadership: http://gsb.columbia.edu/globalbrands Healthcare and Pharmaceutical Management Program: http://gsb.columbia.edu/healthcare The Harris Poll: http://theharrispoll.com